Aurobindo Pharma gets USFDA approval for Sildenafil injection

Aurobindo Pharma gets USFDA approval for Sildenafil injection; Maintain BUY with PT of Rs1,412 | Aurobindo Pharma (ARBP IN) has received final approvals from the USFDA to manufacture and market Sildenafil Injection, 10mg/12.5mL (0.8mg/mL). Sildenafil Injection 10mg/12.5mL (0.8mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD), Revatio, of Pfizer. Sildenafil Injection is indicated for the treatment of adult patients (e” 18 years) with pulmonary arterial hypertension who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.

(IndiaNivesh Report)